1-2 of 2
Yota Yasumizu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy

Open Access
Subject Area:
Further Areas
Ryuichi Mizuno, Kimiharu Takamatsu, Yota Yasumizu, Nobuyuki Tanaka, Toshikazu Takeda, Shinya Morita, Kazuhiro Matsumoto, Takeo Kosaka, Hiroshi Asanuma, Shuji Mikami, Mototsugu Oya
Journal: Urologia Internationalis
Urol Int (2022) 106 (11): 1145–1149.
https://doi.org/10.1159/000521960
Published Online: 09 February 2022
View article titled, Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy
Open the PDF for Predictors of Survival in Favorable Risk Patients with Metastatic Renal Cell Carcinoma Treated with a Single-Agent First-Line Therapy in another window
Journal Articles

Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient

Available to Purchase
Subject Area:
Further Areas
Hiroki Ide, Atsuko Satou, Katsura Hoshino, Yota Yasumizu, Yasumitsu Uchida, Yuji Tasaka, Takeshi Masuda
Journal: Urologia Internationalis
Urol Int (2011) 87 (2): 245–247.
https://doi.org/10.1159/000327511
Published Online: 28 June 2011
View article titled, Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient
Open the PDF for Successful Management of Metastatic Urothelial Carcinoma with Gemcitabine and Paclitaxel Chemotherapy in a Hemodialysis Patient in another window